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Angiogenic sprouting relies on collective migration and coordinated rearrangements of
endothelial leader and follower cells. VE-cadherin-based adherens junctions have emerged as
key cell-cell contacts that transmit forces between cells and trigger signals during collective
cell migration in angiogenesis. However, the underlying molecular mechanisms that govern
these processes and their functional importance for vascular development still remain
unknown. We previously showed that the F-BAR protein PACSIN2 is recruited to tensile
asymmetric adherens junctions between leader and follower cells. Here we report that
PACSIN2 mediates the formation of endothelial sprouts during angiogenesis by coordinating
collective migration. We show that PACSIN2 recruits the trafficking regulators EHD4 and
MICAL-L1 to the rear end of asymmetric adherens junctions to form a recycling endosome-
like tubular structure. The junctional PACSIN2/EHD4/MICAL-L1 complex controls local VE-
cadherin trafficking and thereby coordinates polarized endothelial migration and angiogen-
esis. Our findings reveal a molecular event at force-dependent asymmetric adherens junc-
tions that occurs during the tug-of-war between endothelial leader and follower cells, and
allows for junction-based guidance during collective migration in angiogenesis.
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Sprouting angiogenesis, the formation of new blood vesselsthat originate from pre-existing vasculature, is an essentialprocess for development, wound healing, and tumorigen-
esis. Coordinated endothelial migration and rearrangements drive
angiogenesis, and are important for related vascular develop-
mental processes such as anastomosis, lumen formation, and
valve morphogenesis1–5. Angiogenic sprouts are formed by
migrating endothelial leader cells (tip cells), which are directly
connected to endothelial follower cells (stalk cells), which mediate
sprout elongation and vessel branching6–8. Endothelial cell–cell
contacts are formed through VE-cadherin-based adherens junc-
tions (AJs). AJ remodeling is needed to allow the formation of
angiogenic sprouts from the vascular endothelium, whereas sta-
bilization of AJs supports the integrity of newly formed vessels.
Hence, a tight regulatory system that is responsible for the
making and breaking of endothelial cell–cell contacts is needed
for proper sprouting angiogenesis and vascular barrier
function9–11. Although the importance of VE-cadherin-based AJs
in angiogenesis has already been well recognized, the molecular
events that explain the spatiotemporal turnover of AJs between
leader and follower cells are still poorly understood.
VE-cadherin is a transmembrane receptor that connects neigh-
boring cells by forming extracellular homotypic adhesions11–14.
Intracellularly, VE-cadherin binds to the actin cytoskeleton via β-
catenin and α-catenin proteins11. Besides its function as a structural
anchor between endothelial cells and their actomyosin cytoskeleton,
VE-cadherin possesses important mechanotransduction properties,
which coordinate endothelial collective behavior15–18. Cytoskeletal-
derived forces remodel the organization, protein composition, and
function of AJs in cultured endothelial cells15,16,19–21 and in the
endothelium of developing blood vessels4,7,22. In turn, cytoplasmic
molecular adaptations within the AJ complex are propagated
over multicellular distances via the extracellular VE-cadherin
connections23,24. Such mechanically coupled AJ signaling ensures
the finely tuned collective behavior of the endothelium in response
to pushing and pulling forces from neighboring cells24–28.
During collective cell migration, actomyosin contractions occur
at the rear of the leader cells, which pulls along the front of the
follower cells. These pulling forces at the interface between leader
and follower cells produce tension on the cell–cell contacts,
leading to the formation of asymmetric AJs14,29–31. Tensile AJs
are essential for collective dynamics in cell monolayers26,27. The
polarized trafficking of cadherin-based adhesions is thought to
drive this phenomenon32. The formation of asymmetric tensile
AJs is accompanied by local curvature of the junctional plasma
membrane19,33. We previously showed that recruitment of the
curvature-sensing F-BAR protein PACSIN2 (protein kinase C
and casein kinase 2 substrate in neurons 2) occurs specifically at
the rear of asymmetric AJs in the follower cells19. Intriguingly, the
formation of asymmetric AJs precedes the change in the direction
of collectively migrating cells, suggesting that BAR proteins
provide follower cells with guidance signals in vitro14,33. The
identification of BAR proteins as molecular players at AJs added
curvature sensing of the plasma membrane as contributor to
mechanotransduction and junctional remodeling. The previous
studies were performed with endothelial cell cultures, and
although PACSIN2-positive asymmetric junctions have been
observed in human blood vessels as well, to this date, the func-
tional importance of junction-based signaling through BAR
proteins in endothelial collective behavior and vascular develop-
ment remains unknown. In addition, the molecular systems
responsible for PACSIN2-driven remodeling of VE-cadherin at
asymmetric junctions have not yet been identified.
Here, we reveal that junctional PACSIN2 signaling guides
endothelial cells during angiogenesis. Our results show that
PACSIN2 mediates endothelial front–rear polarity during
collective migration by recruiting the trafficking regulators EHD4
and MICAL-L1 specifically to asymmetric AJs formed between
endothelial leader and follower cells. The junctional PACSIN2/
EHD4/MICAL-L1 complex controls VE-cadherin trafficking and
coordinates endothelial migration and angiogenesis. Together,
these data show that tensile asymmetric AJs harbor a plasma
membrane-bound tubular recycling compartment with marked
importance in AJ remodeling and control over endothelial col-
lective migration in the developing vasculature. These findings
provide a mechanistic explanation for the established hypothesis
of long-range guidance communication between endothelial cells
during angiogenesis.
Results
PACSIN2 controls sprouting angiogenesis in vivo. The F-BAR
protein PACSIN2 is recruited to the rear of AJs between endo-
thelial leader–follower cells in vitro to locally protect junctional
integrity19. In vitro cultured endothelial cells express the PAC-
SIN2 and PACSIN3 isoforms, but no PACSIN119. We first
immuno-stained postnatal day 6 (P6) wild-type retinas and
confirmed that PACSIN2, but not the related PACSIN3 isoform,
is expressed in the endothelium of the developing vasculature of
the retina in vivo (Supplementary Fig. 1a). Next, we generated
homozygous Pacsin2−/− knockout mice through homologous
recombination and ubiquitous Cre-loxP recombination (Supple-
mentary Fig. 1b–d, see “Methods”). Lack of PACSIN2 protein
expression was confirmed in the retina and lung tissue from the
Pacsin2−/− mice. Pacsin2 gene deletion resulted in a slight
increase in PACSIN1 and PACSIN3 protein levels in the overall
Pacsin2−/− retinal tissue (Supplementary Fig. 1e). Pacsin2−/−
mice are viable, fertile and adult mice appear healthy without
major defects or bleedings, which indicates that there is no pro-
minent vascular barrier defect. Some mild delays in cardiomyo-
cyte development were previously reported in Pacsin2−/− mice34.
To investigate the role of PACSIN2 during angiogenesis, we
compared the developing vasculature in control (Pacsin2+/+) and
Pacsin2−/− mice retinas at P6. Pacsin2−/− P6 retinas did not
show explicit differences in the number of developing vascular
branches and sprouts at the vascular front (Fig. 1a, c). However,
we noticed that the vascular sprouts were shorter, albeit com-
posed by a higher number of endothelial cells (Fig. 1b–d). This
coincided with the formation of abnormal angiogenic sprouts,
constituted by endothelial clusters of three or more cells, instead
of the clear leader and follower cells that generate sprouts in
control vessels (Fig. 1b, d). Pacsin2−/− retinas showed no dif-
ferences in the number of endothelial dividing cells (Fig. 1d). This
suggests that the increase in endothelial cell numbers at the
vascular sprouts is not due to proliferative changes, but might
relate to differences in endothelial cell organization. Furthermore,
we observed no changes in the number of endothelial tip cells at
the sprouting front in Pacsin2−/− retinas, as defined by endo-
thelial cell-specific molecule 1 (ESM1) staining (Fig. 1d and
Supplementary Fig. 2a).
Endothelial cell migration and rearrangements in angiogenic
sprouts requires the remodeling of the VE-cadherin-based
AJs4,7,35. High-magnification imaging of VE-cadherin stainings
revealed that the AJs in angiogenic vessels in the Pacsin2−/−
retinas are differently organized (Fig. 1e). Notably, we observed
an increase in cytoplasmic VE-cadherin intensity at the sprouting
front in the Pacsin2−/− retinas (Fig. 1e, f), a feature which has
been shown to associate with the remodeling of AJs between
endothelial leader and follower cell during angiogenesis7.
Moreover, the VE-cadherin junctions were completely disorga-
nized in the large endothelial clusters at the sprouting front in the
Pacsin2−/− retinas (Supplementary Fig. 2b). Taken together,
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these findings show that PACSIN2 is needed for endothelial
organization during sprouting angiogenesis and that PACSIN2
modulates VE-cadherin-based endothelial junctions in vivo.
Endothelial PACSIN2 coordinates collective migration and
angiogenic sprouting. To understand how PACSIN2 controls
endothelial cell movement, we examined in vitro cultured pri-
mary human umbilical vein endothelial cells (HUVECs) in which
PACSIN2 expression was depleted by specific short hairpin RNAs
(shRNAs, previously validated in ref. 19) (Fig. 2a). Multicellular
spheroids composed of shControl or shPACSIN2 HUVECs
were placed in 3D collagen matrices36 to assess VEGF-induced
sprouting capacity. Sprout formation and elongation from
spheroids was strongly decreased upon depletion of PACSIN2
(Fig. 2b, c), confirming that PACSIN2 is needed for endothelial-
driven angiogenic sprouting. We next performed scratch wound
assays of monolayers formed by shControl or shPACSIN2
HUVECs. Depletion of PACSIN2 inhibited cell migration toward
the scratch resulting in delayed wound closure (Fig. 2d, e and
Supplementary Movie 1). Moreover, applying particle image
velocity (PIV) analysis27,37,38 to the time-lapse recordings
revealed that there is a strong decrease in the correlated migration
of a given cell and its neighbors upon depletion of PACSIN2
(Fig. 2f). To decipher whether the depletion of PACSIN2 results
in a cell-intrinsic or a collective migration defect, we performed
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generated in which half of the HUVECs expressed shControl with
an RFP tag and the other half of the HUVECs expressed
shPACSIN2 and GFP. Next, scratch assays were performed and
the identity of the front row cells during collective migration was
determined. The experiments demonstrated that at 12 h after
scratch the migrating front is dominated by cells that express
PACSIN2, whereas PACSIN2-depleted cells fail to follow during
the collective cell migration process (Fig. 2g–i). These findings
indicate that PACSIN2 is needed for coordinated collective cell
migration.
Next, we studied whether PACSIN2 might control the front–rear
polarization of migrating ECs. Efficient collective migration is
tightly dependent on the ability of the cells to polarize toward a
directional cue39,40, and in polarized migrating endothelial cells, the
Golgi is located in front of the nucleus41,42. We assessed Golgi
localization in the first two rows of scratch wound migrating
shControl and shPACSIN2 HUVECs (Fig. 2j). The Golgi was
considered oriented if localized within a 120° margin relative to the
nucleus and the leading edge of the cells (Fig. 2k). These
experiments demonstrate a strong reduction in cell polarization
upon PACSIN2 depletion (Fig. 2l). To determine the importance of
PACSIN2 for endothelial polarization during angiogenesis in vivo,
we investigated Golgi orientation in ECs at the angiogenic front in
control and Pacsin2−/− P6 retinas. Pacsin2−/− ECs were strongly
impaired in their capacity to polarize toward the sprouting front
(Fig. 2m–o). Taken together, these results indicate that PACSIN2 is
needed for endothelial migration by supporting cell collectivity and
polarity during angiogenesis.
PACSIN2 recruitment occurs in parallel with the dissociation
of p120-catenin from VE-cadherin. Our previous study has
shown that asymmetric AJs are formed between the leader and
the follower cells during directed migration, and that PACSIN2 is
recruited to the rear side of these contacts in the follower cells
(Fig. 3a and ref. 19). Since AJ turnover is essential for efficient
collective migration2,32,43–45, and PACSIN2 locally controls VE-
cadherin dynamics at asymmetric AJs19, we next investigated how
PACSIN2 regulates VE-cadherin turnover. P120-catenin binds to
the juxtamembrane domain of the VE-cadherin cytoplasmic tail
where it masks an endocytic motif46,47. P120-catenin dissociation
exposes this motif and induces clathrin-dependent endocytosis of
the VE-cadherin receptor48,49. To establish whether PACSIN2
and p120-catenin are functionally associated, we performed
immunofluorescence (IF) imaging of endogenous p120-catenin,
PACSIN2, and VE-cadherin in HUVECs (Fig. 3b). Linescan
analysis across individual asymmetric AJs revealed that p120-
catenin is released from the trailing ends of PACSIN2-positive,
but not PACSIN2-negative, asymmetric AJs (Fig. 3c, d). In
addition, live imaging of HUVECs expressing PACSIN2-GFP,
p120-catenin-mCherry, and live-labeled VE-cadherin showed
that PACSIN2 is recruited to the asymmetric AJs after p120-
catenin dissociates from VE-cadherin (Supplementary Movie 2
and Supplementary Fig. 3a). Together these data demonstrate that
PACSIN2 is recruited to the asymmetric AJs that are locally
primed for internalization due to the release of p120-catenin from
the VE-cadherin complex.
We next investigated if PACSIN2 is a member of the constitutive
endocytic machinery recruited to VE-cadherin after p120-catenin
dissociation48,50. First, endogenous VE-cadherin was depleted from
HUVECs by lentiviral shRNAs targeting the 3′-untranslated region
(3′-UTR) of the CDH5 messenger RNA (Supplementary Fig. 3b).
These VE-cadherin knockdown cells were rescued by ectopic
expression of wild-type VE-cadherin-GFP, VE-cadherin[DEE]-
GFP, or VE-cadherin[GGG]-GFP; two previously described VE-
cadherin variants that contain mutations at the core p120-catenin
binding site (Fig. 3e, f). Both VE-cadherin mutants do not bind to
p120-catenin. However, the DEE mutation prevents endocytosis of
VE-cadherin and affects endothelial polarization and retinal
angiogenesis, while the GGG mutation still allows for VE-
cadherin internalization48,51. IF imaging of the generated endothe-
lial cell lines shows that recruitment of endogenous PACSIN2 to
VE-cadherin-, VE-cadherin[DEE]-, and VE-cadherin[GGG]-based
asymmetric AJs occurs at comparable levels (Fig. 3e, g). This
indicates that junctional recruitment of PACSIN2 occurs in parallel
with the mechanism driving p120-catenin controlled VE-cadherin
endocytosis.
PACSIN2, EHD4, and MICAL-L1 bind to each other at the
trailing end of asymmetric AJs. To identify the mechanism
through which PACSIN2 controls VE-cadherin turnover, we next
looked at potential PACSIN2 interactors involved in protein
trafficking. PACSIN2 contains Asn-Pro-Phe (NPF) motifs that
bind to the EH domain of the dynamin-like C-terminal Eps15
homology domain (EHD) proteins52 (Fig. 4a). There are four
known mammalian EHD proteins, which are linked to different
branches of endocytic pathways53–55. IF imaging in HUVECs
revealed that PACSIN2 colocalizes clearly with EHD4, and to a
certain extent with EHD1, in a tubular fashion at the asymmetric
AJs (Fig. 4b). No junctional colocalization between PACSIN2
and EHD2 or EHD3 was observed. Quantified Pearson’s
Fig. 1 Abnormal sprouting during retinal angiogenesis in Pacsin2−/− mice. a Immunofluorescent images of whole-mount retinas stained for Isolectin B4
(IB4, red, as marker of blood vessels) and the endothelial transcription factor ERG (cyan, marker of endothelial nuclei) from control (Pacsin2+/+) and
Pacsin2−/− mouse littermates at P6. Representative images of at least ten retinas per genotype from three independent littermates. White rectangles
indicate regions of interest (ROI) of which magnifications are shown below. b Representative images of the sprouting front of retinas from control and
Pacsin2−/− mouse littermates at P6 stained for ERG (red), IB4 (blue), and VE-cadherin (green). Punctuated lines indicate the sprouting front boundary. The
red arrows indicate nuclear clusters in abnormal sprouts. c Quantification of the number of branch points per unit of area, the number of sprouts per 100
µm of sprouting front border, and the average length of sprouts (at least n= 10 retinas per genotype, from three independent littermates). P= 0.0295
when comparing the sprout length in Pacsin2+/+ to Pacsin2−/− retinas. d Quantification of the number of nuclei per 100 µm of sprouting front border, the
number of endothelial cell clusters per sprout, and the percentage of proliferating cells based on cytoplasmic (dividing cells) versus nuclear ERG (non-
dividing cells) stainings per unit area in the sprouting front of control and Pacsin2−/− P6 retinas (at least ten retinas per genotype, from at least three
independent littermates). P= 0.0015 when comparing the number of nuclei, and P= 0.0242 when comparing the number of endothelial clusters in Pacsin2
+/+ to Pacsin2−/− retinas. Quantification of the number of tip cells (ESM1+) per total number of ECs at the sprouting front (at least four retinas per
genotype, from two independent littermates). e Representative high-resolution images of the sprouting front from control and Pacsin2−/− mice stained for
VE-cadherin (green), ERG (red), and IB4 (blue). The black dotted squares indicate the ROIs that are magnified in the panels below. f Quantification of the
intensity of cytoplasmic VE-cadherin at the vascular sprouts of control and Pacsin2−/− retinas (at least seven retinas per genotype, from two independent
littermates). P= 0.0401 when comparing Pacsin2+/+ to Pacsin2−/− retinas. All quantifications represent mean ± SEM (error bars) and the statistics were
performed by the two-sided Mann–Whitney test. ns non-significant; *P < 0.05; **P < 0.01. Scale bars, 100 and 50 µm (a), 40 µm (b), 20 and 5 µm (e). Arb.
units arbitrary units. Source data are provided as a Source Data file.
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colocalization coefficients confirmed the strongest colocalization
of PACSIN2 with EHD4 (R= 0.62) compared to EHD1 (R=
0.38), EHD2 (R= 0.20), and EHD3 (R= 0.23) at asymmetric AJs
(Fig. 4c).
IF imaging further showed that EHD4, like PACSIN219, is
recruited to the rear of asymmetric AJs in follower cells that are
aligned in the direction of collective migration (Supplementary
Fig. 4). To study whether PACSIN2 and EHD4 bind to each
other, we next conducted GFP-tag-based immunoprecipitations
(IPs) on lysates of HUVECs expressing either PACSIN2-GFP or
EHD4-GFP. Endogenous EHD4 was efficiently pulled down in
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PACSIN2 was co-immunoprecipitated in EHD4-GFP IPs (Fig. 4f,
g). Together, these results indicate that PACSIN2 and EHD4
interact at the asymmetric AJs during collective migration.
Binding of PACSIN2 to EHD proteins occurs during the
biogenesis of the recycling endosome—a tubular recycling
compartment56,57. In addition, EHD4 has been shown to control
cargo recycling58. The lipid-binding MICAL-like protein 1
(MICAL-L1) links EHD proteins to the endocytic recycling
compartment, functions upstream of Rab proteins, and is a
marker for endocytic recycling59,60. IF imaging of HUVECs
revealed that MICAL-L1 is recruited to the trailing end of 31% of
the asymmetric AJs (Fig. 4h, j). Next, to investigate whether
MICAL-L1 is part of the tubular junctional PACSIN2-EHD4
complex at asymmetric AJs between HUVECs, we assessed
colocalization of endogenous MICAL-L1 and ectopically
expressed EHD4-GFP (Fig. 4i, k) or PACSIN2-GFP (Supplemen-
tary Fig. 5). IF-based imaging and Pearson’s coefficient analyses
revealed strong junctional colocalization of MICAL-L1 and
EHD4-GFP (R= 0.72) (Fig. 4i, k), and MICAL-L1 and
PACSIN2-GFP (R= 0.82) (Supplementary Fig. 5). These findings
were further corroborated by the notion that endogenous
MICAL-L1 was readily pulled down in PACSIN2-GFP IPs from
HUVECs (Fig. 4d, l). Taken together, these results demonstrate
that MICAL-L1 interacts with PACSIN2 and EHD4 at the trailing
end of asymmetric AJs to form a tubular recycling compartment.
The PACSIN2/EHD4/MICAL-L1 complex controls VE-
cadherin trafficking at asymmetric AJs. Asymmetric AJs are
remodeled in a front–rear polarized fashion, and local PACSIN2
recruitment protects the integrity of VE-cadherin-based
junctions1,19. Concordantly, the depletion of PACSIN2 leads to
strongly augmented VE-cadherin internalization levels19. To
investigate if the interaction of PACSIN2 with the EHD4/
MICAL-L1 complex controls VE-cadherin-based junction turn-
over, we depleted EHD4 from HUVECs by two different EHD4-
specific shRNAs. IF imaging revealed a clear loss of EHD4 from
the trailing end of asymmetric AJs upon EHD4 depletion (Fig. 5a,
b). Intriguingly, both the recruitment of PACSIN2 and MICAL-
L1 to asymmetric AJs were also perturbed upon EHD4 depletion
(Fig. 5c–f), indicating complete disruption of the junctional
PACSIN2/EHD4/MICAL-L1 complex. Vice versa, depletion of
PACSIN2 prevented the recruitment of EHD4 to asymmetric AJs
(Supplementary Fig. 6). These experiments show that both EHD4
and PACSIN2 are needed to assemble the junctional PACSIN2/
EHD4/MICAL-L1 complex.
HUVECs transduced with shEHD4 were still able to form VE-
cadherin-based junctions and no major cytoskeletal changes were
observed (Fig. 5 and Supplementary Fig. 7a). Fluorescence-activated
cell sorting (FACS) analysis indicate that the depletion of EHD4
does not affect overall cell surface levels of VE-cadherin
(Supplementary Fig. 7b). Next, we determined VE-cadherin
intensity and localization in shControl, shPACSIN2, and shEHD4
monolayers by immunostaining the VE-cadherin molecules on the
cell surface without permeabilization using an anti-VE-cadherin
antibody that recognizes an extracellular epitope of VE-cadherin. In
agreement with the FACS data and our earlier experiments with
shPACSIN2 HUVECs19, we observed no clear differences in VE-
cadherin localization or intensity in the various knockdown
conditions compared to control (Fig. 6a upper images). This
Fig. 2 PACSIN2 controls endothelial directed migration and angiogenic sprouting. a Representative Western blot analysis of PACSIN2 and vinculin
(loading control) expression in whole-cell lysates from HUVECs transduced with shControl, shPACSIN2-D11, and shPACSIN2-E1. Western blots were
repeated three times with similar results. b Representative phase-contrast images of sprouting spheroids from HUVECs transduced with shControl,
shPACSIN2-D11, and shPACSIN2-E1 after 16-h stimulation with VEGF. c Quantification of the number of sprouts per spheroid and the average sprout length
of HUVECs transduced with shControl (n= 63 spheroids), shPACSIN2-D11 (n= 52 spheroids), and shPACSIN2-E1 (n= 67 spheroids). Data are from four
independent experiments. P < 0.0001 when comparing shControl to shPACSIN2-D11 and when comparing shControl to shPACSIN2-E1. d Representative
phase-contrast images of the scratch wound migration assay at 9 h post-scratch performed on HUVEC monolayers transduced with shControl,
shPACSIN2-D11, and shPACSIN2-E1. The punctuated yellow lines indicate the boundaries of the wound. See Supplementary Movie 1 for time-lapse images
of the scratch wound migration. e Quantification of wound-healing velocity measured in surface area per min of post-scratch HUVEC monolayers
transduced with shControl (n= 33 movies), shPACSIN2-D11 (n= 18 movies), and shPACSIN2-E1 (n= 20 movies) from three independent experiments.
P < 0.0001 when comparing shControl to shPACSIN2-D11 and when comparing shControl to shPACSIN2-E1. f Quantification of the correlation length of
wound-healing time-lapse recordings of HUVECs transduced with shControl (n= 23 movies), shPACSIN2-D11 (n= 19 movies), and shPACSIN2-E1 (n= 35
movies) from at least four independent experiments using particle image velocimetry (PIV) analysis. P < 0.0001 when comparing shControl to shPACSIN2-
D11 and P= 0.0358 when comparing shControl to shPACSIN2-E1. g Representative fluorescence images of HUVECs transduced with shControl-RFP or
shPACSIN2 together with GFP in a scratch wound assay (t= 0 and t= 12 h after scratch). The punctuated yellow line highlights the migration front.
h Quantification of the fraction of shControl (RFP) or shPACSIN2 (GFP) cells at the leading edge at t= 0 and t= 12 h after scratch. P < 0.0001 when
comparing shControl to shPACSIN2 at t= 12 h using two-way ANOVA multiple comparisons. Data are from three independent experiments and 20 movies
per condition. i Quantification of the average directionality and velocity of migrating follower shControl (RFP; n= 22 movies) or shPACSIN2 (GFP; n= 22
movies) cells. Directionality data were normally distributed and for comparison a paired two-tailed Student’s t test was performed. P < 0.0001 when
comparing shControl to shPACSIN2-D11. The velocity data were not normally distributed, a paired two-tailed nonparametric Wilcoxon test was performed.
P < 0.0001 when comparing shControl to shPACSIN2-D11. j Representative widefield IF images taken 5 h post-scratch of HUVEC monolayers transduced
with shControl, shPACSIN2-D11, and shPACSIN2-E1 and stained for VE-cadherin (gray), DAPI (blue), and GM130 (green). The punctuated yellow lines
indicate the boundaries of the wound. k A scheme to explain the quantification of Golgi orientation in migrating cells. Golgi was assessed as oriented if
located within the 120° angle area directed toward the migration front of scratch wound assays. l Quantification of the percentage of cells with oriented
Golgi in scratch wound assays with HUVECs transduced with shControl (n= 39 images), shPACSIN2-D11 (n= 23 images), and shPACSIN2-E1 (n= 32
images) from three independent experiments. P= 0.0017 when comparing shControl to shPACSIN2-D11 and P < 0.0001 when comparing shControl to
shPACSIN2-E1. m Representative images of the sprouting front of retinas from control and Pacsin2−/− mouse littermates at P6 stained for ERG (green),
ICAM2 (blue), and GOLPH4 (red). Arrows display the orientation of the Golgi in relation to the nucleus. n Rose plot of the polarization data distribution of
quantified endothelial cells from control and Pacsin2−/− retinas at the first three rows of the vascular sprouting front. o Quantification of the percentage of
polarized endothelial cells as defined within the ±60° range toward the sprouting front. P= 0.0087 when comparing Pacsin2+/+ to Pacsin2−/− (two-sided
Mann–Whitney test). All graphs represent mean ± SEM (error bars), and the statistical analysis was performed by a one-way ANOVA and Dunnett’s
multiple comparisons test unless stated otherwise. ns non-significant; *P < 0.05; **P < 0.01; ***P < 0.001. Scale bars, 50 µm (b, d, g) and 20 µm (j, m).
t time. Source data are provided as a Source Data file.
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indicates that global VE-cadherin-based junction biogenesis
pathways are unaffected. To study if EHD4, like PACSIN2, controls
VE-cadherin trafficking, we pulse-labeled VE-cadherin molecules
on the surface of shControl, shPACSIN2, and shEHD4 HUVECs
and followed their turnover and internalization. These experiments
show that in a time course of 2 h, a larger proportion of
VE-cadherin is internalized and accumulating in intracellular
vesicles upon depletion of PACSIN2 or EHD4 (Fig. 6a, b).
Live imaging of HUVECs expressing EHD4-GFP and
VE-cadherin-mCherry showed that the recruitment of EHD4
relates to rapid movements of the asymmetric AJs (Fig. 6c and
Supplementary Movie 3). To investigate whether EHD4 controls
local turnover of the AJs, VE-cadherin-GFP was expressed in
shControl and shEHD4 HUVECs. Subsequent live cell imaging
experiments clearly showed that the asymmetric AJs are gradually
turning over during their movement through subtle internaliza-
tion events (Fig. 6d and Supplementary Movie 4). Importantly,
upon the depletion of EHD4, the asymmetric AJs are not turning
over in a smooth fashion, but instead elongate until they
break (Fig. 6d and Supplementary Movie 4). This junctional
defect in shEHD4 HUVECs likely underlies the accumulation of
VE-cadherin-positive vesicles in the pulse-chase experiments.
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We next investigated if EHD4 controls remodeling of AJs
during endothelial collective migration. To study this, we live-
labeled VE-cadherin in shControl or shEHD4 HUVEC mono-
layers and induced a scratch wound to trigger collective
migration. Both shEHD4 and shControl HUVECs established
asymmetric AJs between the leader and follower cells (Fig. 6e).
Live imaging revealed that the asymmetric AJs in shControl
HUVECs were gradually resolved, allowing for the dynamic
breaking and making of cell–cell contacts to support the
coordination of polarized cell migration (Fig. 6e and Supplemen-
tary Movie 5). Strikingly, in the shEHD4 HUVECs the majority of
asymmetric AJs persisted longer, and the asymmetric AJs
elongated, supporting the notion that VE-cadherin is not properly
trafficked (Fig. 6e and Supplementary Movie 5). This resulted in
increased maximal junctional length and prolonged lifetime of
the asymmetric AJs between EHD4 knockdown cells (Fig. 6f, g).
Together, these findings clearly show that the PACSIN2/EHD4/
MICAL-L1 complex mediates proper VE-cadherin trafficking at
asymmetric junctions.
The PACSIN2/EHD4/MICAL-L1 complex is needed for endo-
thelial collective migration and sprouting angiogenesis. Next,
we validated the functional importance of the PACSIN2/EHD4/
MICAL-L1 complex for endothelial collective behavior. HUVECs
depleted of EHD4 exhibited an approximate twofold delay in
wound closure compared to control cells (Fig. 7a, b and Sup-
plementary Movie 6), similar to the migration capacity of
shPACSIN2 HUVECs (Fig. 2d, e). The correlation length between
neighboring migrating shEHD4 HUVECs is reduced compared to
shControl (Fig. 7c), indicative of a loss of collectively coordinated
endothelial cell migration upon EHD4 depletion. In addition, the
depletion of EHD4 impaired VEGF-induced sprouting and
sprout elongation in 3D collagen matrices (Fig. 7d, e). Based on
the notion that these effects are comparable to the functional
defects in shPACSIN2 HUVECs (Fig. 2), we conclude that
assembly of the junctional PACSIN2/EHD4 complex supports
asymmetric AJ remodeling for collective endothelial migration.
We next investigated the role of EHD4 in retinal angiogenesis.
Immunostaining of P6 wild-type retinas showed that EHD4 is
highly expressed in the retinal vasculature and associates with
VE-cadherin junctions to some extent (Supplementary Fig. 8a).
To establish the importance of EHD4 in vascular development,
we generated homozygous Ehd4−/− knockout mice through
homologous recombination and ubiquitous Cre-loxP recombina-
tion (Supplementary Fig. 8b, see “Methods”). Depletion of EHD4
was confirmed in the retina and lung tissue of the Ehd4−/− mice,
and Ehd4 gene deletion did not affect the expression of the
related EHD1, EHD2, and EHD3 isoforms (Supplementary
Fig. 8c). Ehd4−/− mice are viable, fertile, and develop toward
adulthood, including development of retinal vasculature with
equal number of vascular branch points, sprouts, and endothelial
cell numbers (Fig. 7f, g). Notably, the deletion of EHD4 resulted
in a decrease in the endothelial sprout length and an increase in
the number of endothelial cell clusters at the angiogenic front of
the developing vasculature in P6 retinas (Fig. 7h, i). Also, we
observed a slight increase (not significant) in cytoplasmic VE-
cadherin signal in the angiogenic endothelial cells in Ehd4−/−
retinal vasculature compared to controls (Fig. 7 j, k).
Taken together, these results show that EHD4, like PACSIN2,
controls endothelial collective migration and angiogenic sprout-
ing. Altogether, these data support the notion that the PACSIN2/
EHD4/MICAL-L1 complex forms a tubular trafficking compart-
ment at asymmetric AJs that is required for coordinated
endothelial cell migration and rearrangements during sprouting
angiogenesis.
Discussion
The ability of the endothelium to adapt as collective tissue is crucial
for vascular development and maintenance of the vascular barrier
in the mature organism. Communication between leading tip cells
and following stalk cells orchestrates the development of a proper
vascular bed and involves direct anchoring, signaling, and orien-
tation between the endothelial cells2,7. AJs are essential hubs of cell-
to-cell communication during collective tissue behavior. Although
the importance of mechanical coupling between the leader and
follower cells through cadherin-based adhesions has been well
established11,61–64, we have only just begun to appreciate the extent
to which junctional-derived signaling events guides collective
behavior. Our data reveal that the F-BAR protein PACSIN2 acts as
a sensor between leader and follower cells by recruiting the traf-
ficking modulators EHD4 and MICAL-L1 to the rear of asymmetric
AJs. We find that formation of the junctional PACSIN2/EHD4/
MICAL-L1 complex drives proper turnover of VE-cadherin at
remodeling AJs (Fig. 8), and we provide proof for the importance of
PACSIN2/EHD4/MICAL-L1 complex signaling for endothelial
collective migration and sprouting angiogenesis in vitro and in vivo.
Together, these results put forward asymmetric AJs as important
players at the endothelial leader and follower cell interface, in
addition to the well-established angiogenic signaling cascades, such
as VEGF-VEGFR and Delta-Notch signaling that shape the
angiogenic front.
Fig. 3 PACSIN2 recruitment to asymmetric AJs occurs in parallel with the dissociation of p120-catenin from VE-cadherin. a A schematic representation
and an IF image zoomed-in on asymmetric AJs at the junctional interface of collectively migrating HUVECs. Stained PACSIN2 is represented in green and
VE-cadherin in red. b IF images of asymmetric AJs between HUVECs stained for PACSIN2 (white), p120-catenin (green), and VE-cadherin (red) and dual
and triple channel merges. c On the left—a representative site of a linescan analysis of VE-cadherin and p120-catenin along a PACSIN2-positive
asymmetric AJ (indicated with a solid blue line of 3.5-µm length). On the right—a graph with averages of VE-cadherin and p120-catenin intensities,
normalized and corrected for background, measured along PACSIN2-positive asymmetric AJs (n= 21 asymmetric AJs) from three independent
experiments. d On the left—a representative site of a linescan analysis of VE-cadherin and p120-catenin along a PACSIN2-negative asymmetric AJ. On the
right—a graph with averages of VE-cadherin and p120-catenin intensities, normalized and corrected for background, measured along PACSIN2-negative
asymmetric AJs (n= 13 asymmetric AJs) from three independent experiments. e Representative widefield IF images of asymmetric AJs in HUVECs
depleted for endogenous VE-cadherin and rescued with ectopic expression of VE-cadherin-GFP, VE-cadherin[GGG]-GFP, or VE-cadherin[DEE]-GFP (red)
and stained for endogenous p120-catenin (white) and PACSIN2 (green). The white arrows point to PACSIN2-positive asymmetric AJs. Corresponding
Western blot analysis of endogenous VE-cadherin depletion is shown in Supplementary Fig. 3b. f A schematic representation of the p120-catenin-binding
domain mutated VE-cadherin variants. g Quantification of the percentage of PACSIN2-positive asymmetric AJs detected in VE-cadherin-GFP (n= 22
images), VE-cadherin[DEE]-GFP (n= 27 images), VE-cadherin[GGG]-GFP (n= 24 images) expressing HUVECs from three independent experiments. The
statistical analysis was performed by a one-way ANOVA and Dunnett’s multiple comparisons test. ns non-significant. All graphs represent mean ± SEM
(error bars). Scale bars, 5 µm (a–d) and 10 µm (e). AJs adherens junctions, Arb. units arbitrary units, VEC VE-cadherin. Source data are provided as a
Source Data file.
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Collective migration requires polarized remodeling of the
AJs2,18,65, which is mediated by internalization, sorting, recycling,
and (re)formation of cadherin-based adhesions43,46,50,66–68.
Although the presence of asymmetric AJs has been numerously
described3,19,31,69,70, their role and importance in endothelial
migration and vascular development remained to be established.
Our data reveal that PACSIN2 is recruited to asymmetric AJs that
are primed for endocytosis by the dissociation of p120-catenin
from the VE-cadherin complex. At the trailing rear of asymmetric
AJs, PACSIN2 binds to the recycling regulators EHD4 and
MICAL-L1. Our results further implicate the importance of this
junctional tubular trafficking compartment in balancing the
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breaking and making of AJs during endothelial collective beha-
vior. Recent experiments using transgenic CDH5 knock-in
mouse models, established that the p120-mediated turnover of
VE-cadherin is important for endothelial collective migration
and endothelial cell polarization51. Our current finding that
the PACSIN2-EHD4 complex controls VE-cadherin turnover
and drives endothelial collective migration and angiogenesis is
in strong agreement with the notion that proper trafficking
of VE-cadherin is needed for endothelial polarity and retinal
angiogenesis.
EHD proteins bind to the NPF motifs of PACSIN2 and their
association has been observed in cilia of fibroblasts and epithelial
cells, as well as in the soma and neurites of neuronal cells57,71.
Also, an interaction between PACSIN2, EHD1, and MICAL-L1
was previously shown during the formation of the recycling
endosome at the nuclear periphery56, where it receives cargo
sorted for recycling from the early endosome55,72. Our results
reveal that the PACSIN2/EHD4/MICAL-L1 complex is locally
generated at asymmetric AJs to fit the need of the endothelium to
direct AJ turnover in collective migration. We observed that
MICAL-L1 is also recruited to a fraction of remodeling AJs that
are negative for PACSIN2 (Supplementary Fig 5). This opens up
the possibility that additional NPF-containing BAR proteins and/
or EHD isoforms are involved in the turnover of AJs of different
tubular sizes and/or shapes.
The PACSIN2/EHD4/MICAL-L1 complex may contribute to
VE-cadherin trafficking by targeting the junctional membrane.
EHD1 is known to actively sculpt membranes, thereby driving
membrane scission and promoting endocytic recycling73. Like-
wise, expression of PACSIN2, EHD4, and EHD1 has been shown
to contribute to infectious virus spread by controlling membrane
fission in host cells74,75. Alternatively, the PACSIN2/EHD4/
MICAL-L1 complex may tighten the connections between
endocytic pathways and cytoskeletal adaptations that provide
polarized cues across AJs for collectively migrating cells26,40,70.
Here, we have focussed on the primary signaling events at the
front–rear interface between migrating neighboring cells, where
pulling from the leader cells leads to force-dependent remodeling
of the AJs. Interestingly, similar junction remodeling is observed
in response to other mechanical triggers such as shear stress76
and monolayer stiffness heterogeneity77,78. We therefore expect
that the formation of the PACSIN2/EHD4/MICAL-L1 complex is
not limited to collective cell migration during angiogenesis and
wound healing. We surmise that the complex forms as an
adaptation to a variety of mechanical stimuli that promote rapid
turnover of cell–cell contacts and junctional membrane tension to
protect junction stability and vascular integrity. Given the notion
that PACSIN2 is an ubiquitously expressed protein, experimental
approaches using endothelial-specific conditional knockout
models might further reveal the function of the PACSIN2/EHD4/
MICAL-L1 complex as mechanosensing module and its invol-
vement in vascular homeostasis and pathology.
Methods
Cell culture. We used primary HUVEC (up to passage 5) pooled from different
donors (obtained under informed consent) from Lonza (Cat # C2519A). HUVEC
were cultured on gelatin-coated cell culture dishes in Endothelial Cell Growth
Medium 2 supplemented with the Growth Medium 2 Supplement Pack (EGM-2)
from Promocell. HEK293T cells (ATCC, CRL-3216) were cultured in Dulbecco’s
Medium Eagle medium with L-glutamine supplemented with 10% FCS and
penicillin (100 units mL−1), and streptomycin (100 mgmL−1) (ThermoFisher). All
cells were cultured at 37 °C and 5% CO2.
Mice. We used homologous recombination and the Cre-loxP recombination to
create mice with a loxP-flanked (floxed) expression of the Pacsin2 gene. The tar-
geting vector contained a single loxP site in intron 3 and an FRT-site-flanked neo
cassette with an additional loxP site in intron 4, to allow conditional removal of
exon 4 (Supplementary Fig. 1b). Two independent transfected ES clones with the
correct recombination event were identified by Southern blotting and injected into
blastocysts. Mice carrying the Pacsin2flox(neo) allele were then bred to homozygosity
and crossed with transgenic Flp-recombinase deleter mice to remove the FRT-site
flanked neo cassette (Supplementary Fig. 1b). The resulting homozygous Pac-
sin2flox mice appeared normal, indicating that the genetic manipulation had not
altered the function of PACSIN2. To generate animals lacking PACSIN2 expres-
sion, Pacsin2flox mice were bred to transgenic Cre-deleter mice to produce
PACSIN2-deficient animals carrying the Pacsin2null allele. The removal of exon 4
was confirmed by Southern blotting on DNA from the progeny (Supplementary
Fig. 1c). To check for homologous recombination, ScaI-digested genomic DNA was
analyzed by Southern blotting using a 1.3-kb XhoI-BamHI DNA fragment of a
genomic subclone as external probe (corresponding to nt 165762–166609 of acc.no.
AL583889). This probe identifies an 8.8-kb fragment and a 6.4-kb fragment in the
wild-type and mutant alleles, respectively. We backcrossed these mice onto the
C57BL/6 background for six generations. In homozygous PACSIN2-deficient mice,
very low levels of Pacsin2 transcripts could be detected by Northern blotting
(Supplementary Fig. 1d), but tested retina and lung tissues lacked the PACSIN2
protein (Supplementary Fig. 1e). For Northern blot analysis, RNA was isolated
from freshly prepared tissues using guanidinium thiocyanate lysis, and poly(A)+
RNA was enriched by using the Oligotex mRNA kit (Qiagen). After fractionation
of the RNA by a 1% agarose-formaldehyde gel, and subsequent capillary transfer
onto Hybond XL membrane (Amersham Pharmacia Biotech), hybridization was
performed in a formamide mix and radiolabelled probes were generated by using a
labeling kit (TaKaRa). For isoform-specific hybridization79, the following eluted
DNA fragments of the corresponding Pacsin cDNA clones were used as probes: a
0.36-kb SmaI fragment corresponding to nt 704–1067 of Pacsin1 cDNA (acc.no.
X85124), a 0.25-kb SmaI/NheI fragment corresponding to nt 718–984 of Pacsin2
Fig. 4 PACSIN2, EHD4, and MICAL-L1 interact at asymmetric AJs. a A schematic representation of the domain structures of PACSIN2 and EHD proteins.
NPF Asn-Pro-Phe motif; SH3 SRC homology 3 domain; Hlc helical domain. b Confocal and widefield IF images of asymmetric AJs in HUVECs expressing
PACSIN2-GFP (green) and stained for EHD1, EHD2, EHD3, or EHD4 (red) and VE-cadherin (blue). c Pearson’s correlation analysis of PACSIN2 and EHD
isoform fluorescent signals at the asymmetric AJs. The red numbers represent the mean Pearson’s correlation values (R). Data are derived from three
independent experiments; EHD1/PACSIN2 (n= 22 asymmetric AJs), EHD2/PACSIN2 (n= 26 asymmetric AJs), EHD3/PACSIN2 (n= 23 asymmetric AJs),
EHD4/PACSIN2 (n= 34 asymmetric AJs). d Representative Western blot analysis for EHD4, GFP, and MICAL-L1 on whole-cell lysates and GFP pull-down
samples derived from non-transduced HUVECs (WT), HUVECs expressing GFP, or PACSIN2-GFP. e Quantification of relative EHD4 intensity detected in
GFP pull-down samples from HUVECs expressing GFP or PACSIN2-GFP (n= 3 independent experiments). The signal is normalized to the amount of
protein in the whole-cell lysate. P= 0.0311 when comparing GFP to PACSIN2-GFP. f Representative Western blot analysis for PACSIN2, EHD4, and GFP on
whole-cell lysates and GFP pull-down samples derived from non-transduced HUVECs (WT), HUVECs expressing GFP or EHD4-GFP. g Quantification of
relative PACSIN2 intensity detected in GFP pull-down samples from HUVECs expressing GFP or EHD4-GFP (n= 3 independent experiments). The signal is
normalized to the amount of protein in the whole-cell lysate. P= 0.0375 when comparing GFP to EHD4-GFP. h Widefield IF images of asymmetric AJs in
HUVECs stained for MICAL-L1 (green), F-actin (red), and VE-cadherin (blue). i Widefield IF images of asymmetric AJs in HUVECs expressing EHD4-GFP
(red) stained for MICAL-L1 (green) and VE-cadherin (blue). j Quantification of the percentage of MICAL-L1-positive asymmetric AJs in HUVECs (n= 18
images from three independent experiments). k Pearson’s correlation analysis of fluorescent signal of MICAL-L1 and EHD4-GFP at the asymmetric AJs
(n= 8 images from three independent experiments). l Quantification of relative MICAL-L1 intensity detected in GFP pull-down samples from HUVECs
expressing GFP or PACSIN2-GFP (n= 3 independent experiments). The signal is normalized to the amount of protein in the whole-cell lysate. P= 0.0436
when comparing GFP to PACSIN2-GFP. All graphs represent mean ± SEM (error bars), and the statistical analysis was performed by a paired two-tailed t
test. *P < 0.05. Scale bars, 5 µm (b) and 2.5 µm (h, i). IP immunoprecipitation, Arb. units arbitrary units. Source data are provided as a Source Data file.
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cDNA (acc.no. XM_030248566), and a 0.52-kb SmaI fragment corresponding to nt
854–1379 of Pacsin3 cDNA (acc. no. NM_028733), respectively. The filters were
stringently washed before autoradiography. Prior ethidium bromide staining of the
gel and hybridization with glycerin aldehyde-3-phosphate dehydrogenase cDNA
were used to control equal loading and to check RNA integrity.
The Ehd4 mutant mice were commercially generated by inGenious Targeting
Laboratory, Inc. (Stony Brook). Briefly, for the construction of the floxed Ehd4
targeting vector, a genomic fragment spanning a total of 10.05 kb of Ehd4 sequence
including exon 1 was isolated from a C57BL/6 BAC clone (RP23: 108D15) using a
homologous recombination-based technique. The final construct was designed
such that the long homology arm extends 6.8 kb from the 5′-end of the single loxP
site located upstream of exon 1 (Supplementary Fig. 8b). The short homology arm
extends 2.2 kb from the 3′-end of the loxP/FRT-site-flanked neo cassette, which was
inserted downstream of exon 1. The target region spans ~1.0 kb containing exon 1.
The resulting targeting construct was linearized by cutting at the NotI restriction
site located within the vector backbone 3′ of the sequence homologous to Ehd4.
Linearized DNA was electroporated into C57BL6/129SvEv hybrid embryonic stem
cells. Homologous recombination events were identified by Southern blot analysis
using external and internal probes. Four correctly targeted ES cell clones were
isolated and injected into C57/BL6 blastocysts to generate chimeric mice. To
generate EHD4-deficient animals, homozygous Ehd4flox mice were crossed to Cre-
deleter mice, yielding ubiquitous disruption of the Ehd4 gene (Supplementary
Fig. 8b).
All mouse studies were performed after ethical approval for breeding and
maintaining mice by local government authorities (Landesamt für Natur, Umwelt
und Verbraucherschutz Nordrhein-Westfalen (permission number no. 81-
02.04.2019A215, Germany) in accordance with the German animal protection law
and with permission to sacrifice mice for scientific purpose. Animals were housed
in the Center for Molecular Medicine animal care facility of the University of
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conditions with a 12-h light/dark schedule and provided with food and water ad
libitum. Experimental procedures were performed according to all relevant ethical
regulations for animal testing and research.
Antibodies. Detection of PACSIN2 was performed with purified rabbit polyclonal
anti-human PACSIN2 antibody (Cat # AP8088b; diluted 1/100 for IF; 1/5000 for
Western Blot) obtained from Abgent and affinity-purified antibodies against mouse
PACSIN2 and PACSIN3 (dilution 1/100 for IF) raised in rabbit were from the
laboratory of M.P. We used purified mouse anti-human p120-catenin antibody
(Clone 98/pp120, Cat # 610134; diluted 1/100 for IF) obtained from BD Bios-
ciences. Imaging of VE-cadherin was performed with the following antibodies:
purified goat anti-human VE-cadherin (Clone C-19, Cat # SC-6458, diluted 1/100)
from Santa Cruz, rabbit polyclonal anti-human VE-cadherin (Cat # 160840, diluted
1/100 for IF) from Cayman Chemical, mouse anti-cadherin-5 (Clone 75, Cat #
610252, diluted 1/100 for IF; and 1/1000 for Western Blot), rat anti-mouse VE-
cadherin (BD Bioscience, #555289, diluted 1:50 for IF retinas), and directly labeled
Alexa Fluor-647 mouse anti-human CD144 (Clone 55-7H1; Cat # 561567; diluted
1/200) from BD Biosciences. Affinity-purified antibodies against human EHD1,
EHD2, EHD3, and EHD4 (dilution 1/100 for IF, 1/1000 for Western Blot) raised in
rabbit were a gift from the laboratory of M.P. We used rabbit monoclonal anti-ERG
(Clone EPR3864, #AB92513, diluted 1:400 for IF) from Abcam, polyclonal goat
anti-endocan/ESM1 (1/100 for IF, Cat # AF1999) from R&D Systems, purified rat
anti-ICAM2 (Clone 3C4 (mIC2/4), 1/100 for IF, Cat # 553326) from BD Phar-
mingen, and purified polyclonal rabbit anti-human MICAL-L1 (Cat # NBP2-
55389; diluted 1/100 for IF, 1/1000 for Western Blot) antibody from Novus Bio-
logicals. IF of Golgi was performed with purified mouse anti-GM130 (clone 35, Cat
# 610823, diluted 1/200) antibody obtained from BD Biosciences in HUVECs and
with the rabbit polyclonal anti-GOLPH4 (1/100 for IF, Cat # ab28049) from
Abcam in mouse retinas. IF of cell nuclei was performed with DAPI (Invitrogen;
diluted 1/1000). To perform IF on F-actin, we used PromoFluor-415 Phalloidin
(Cat # PK-PF415-7-01, diluted 1/200) from Promokine. For IF with fixed cells, the
following secondary antibodies from Invitrogen (diluted 1/200) were used: chicken
anti-mouse Alexa Fluor-488 (Cat # A21200), chicken anti-rabbit Alexa Fluor-488
(Cat # A21441), chicken anti-mouse Alexa Fluor-594 (Cat # A21201), chicken anti-
rabbit Alexa Fluor-594 (Cat # A21442), chicken anti-mouse Alexa Fluor-647 (Cat #
A21463), chicken anti-rabbit Alexa Fluor-647 (Cat # A21443), and chicken anti-
goat Alexa Fluor-647 (Cat # A21469). For IF stainings in the retina, the following
labels and secondary antibodies from Invitrogen were used at 1/300 dilution:
Isolectin GS-IB4 Alexa Fluor-488 (Cat # I21411), Isolectin GS-IB4 Alexa Fluor-568
(Cat # I21412), Isolectin GS-IB4 Alexa Fluor-647 (Cat # I32450), goat anti-rabbit
Alexa Fluor-488 (Cat # A11008), goat anti-rabbit Alexa Fluor-568 (Cat # A11011),
goat anti-rat Alexa Fluor-488 (Cat # A11006), and goat anti-rat Alexa Fluor-633
(Cat # A21094). As loading control for Western Blot, we used mouse monoclonal
anti-human vinculin (Clone hVIN-1, Cat # V9131, diluted 1/1000) antibody from
Sigma-Aldrich. To detect GFP in Western Blot, we used mouse anti-GFP (Clone B-
2, Cat # sc-9996, dilution 1/1000) antibody from Santa Cruz. For Western Blot
protein detection, we used horseradish peroxidase-coupled goat anti-mouse
(A28177) and goat anti-rabbit (A27036) secondary antibodies (diluted 1/1000)
from Invitrogen.
DNA plasmids and lentiviral transduction. PACSIN2 and EHD4 knockdowns
were performed using pLKO.1 lentiviral vectors expressing shRNAs targeting
human PACSIN2 or EHD4. The shRNA constructs were obtained from The RNAi
Consortium (TRC) library80. For PACSIN2 knockdown, we used MISSION TRC1
clones 0000037980 and 0000037983 designated as clone shPACSIN2-E1 and D11
throughout the manuscript. For EHD4 knockdown, we used MISSION TRC1
clones 0000053400 and 0000053401, designated as shEHD4-E10 and shEHD4-E1
throughout the manuscript. As a negative control, we used non-targeting shRNA
(SHC002) from Sigma-Aldrich. shVE-cadherin-3′UTR was created by allowing two
oligos containing the shRNA sequence 5′-CCGGTGGATAGCAAACTCCAGGT
TCCCTCGAGGGAACCTGGAGTTTGCTATCCTTTTTG-3′ to self-ligate. The
product was then inserted into a modified version of pLKO.1 EV U6 backbone
between the AgeI and EcoRI restriction sites. For ectopic expression of EHD4-GFP,
human EHD4 cDNA was amplified by PCR from a peGFP-EHD4 plasmid (gift
from Prof. Dr Steve Caplan). The PCR product was then cloned into a pLV-CMV-
ires-puro vector using the Sequence- and Ligation-Independent Cloning method81
and Xbal and Nhel restriction sites. The Aspartate-Glutamate-Glutamate (GACG
AGGAG) to Alanine-Alanine-Alanine (GCAGCAGCA) mutations at position
646–648 and Glycine-Glycine-Glycine (GGCGGCGGC) to Alanine-Alanine-
Alanine (GCAGCAGCA) mutations at position 649–651 in the VE-cadherin
cytoplasmic domain were achieved by site-directed mutagenesis in the peGFP-VE-
cadherin plasmid15. Next, these plasmids were digested with PstI and Bpu1102I
restriction enzymes. The 816-bp fragment, containing the mutations, was
exchanged with the wild-type fragment from lentiviral plasmid pLV-CMV-VE-
cadherin-eGFP-ires-puro15 to generate the lentiviral pLV-CMV-VE-cadherin-
[DEE646-648AAA]-eGFP and pLV-CMV-VE-cadherin-[GGG649-651AAA]-
eGFP plasmids. The lentiviral expression constructs pLV-PACSIN2-GFP, pLV-VE-
cadherin-mCherry, and pLV-p120-catenin-mCherry have been described
before15,19. Lentiviral particles were produced in HEK293T cells, which were
transiently transfected with third-generation packaging constructs and the lenti-
viral expression vector of interest using Trans-IT LTI (Mirus). HUVECs at 60%
confluency were transduced with the lentiviral particles overnight. HUVECs
transduced with shRNAs were analyzed at least 72 h post transduction. For primer
sequences, see Supplementary Table 1.
IF staining. For standard IF stainings, HUVECs were cultured on coverslips coated
with 5-µg ml−1 human plasma fibronectin (Sigma-Aldrich). Cells were then fixed
in 4% PFA diluted in PBS supplemented with 1-mM CaCl2 and 0.5-mM MgCl2
(PBS++) for 10 min. After fixation, the cells were permeabilized with 0.5% Triton
X-100 in PBS and blocked with 2% bovine serum albumin (BSA) in PBS. Primary
and secondary antibodies were diluted in 0.5% BSA in PBS and incubated in dark
for 1 h each. After each incubation, the coverslips were thoroughly washed in 0.5%
BSA in PBS. After the last wash, the coverslips were mounted on microscope slides
in Mowiol4-88 (Calbiochem, #475904) and DABCO (Sigma-Aldrich, D27802)
solution.
For retinal IF, isolated eyes from postnatal day 6 mice were fixed in 4% PFA in
PBS for 1 h on ice and washed in PBS for at least 10 min. Retinas were dissected
from the eyes and fixed with 4% PFA in PBS for 1 h on ice. Retinas were washed
with PBS and blocked with blocking buffer (1% BSA, 0.3% Triton X-100 in PBS)
overnight at 4 °C. Next, retinas were incubated with the specific primary antibodies
diluted in blocking buffer overnight at 4 °C. Retinas were washed three times in
PBST and 30 min at room temperature with Pblec (1-mM MgCl2, 1-mM CaCl2,
0.1-mM MnCl2, 1% Triton X-100 in PBS). Retinas were incubated for 2 h at room
temperature or overnight at 4 °C with Isolectin B4 (IB4, Invitrogen, #I21412,
diluted 1:300) and the corresponding secondary antibodies in Pblec. Subsequently,
the retinas were washed three times with PBST and flat-mounted on microscope
glass slides with Mowiol/DABCO. For IF stainings of the Golgi (anti-GOLPH4)
and EC nuclei (anti-ERG) in retinas (both primary antibodies are raised in the
same species), an extra step was performed82. After incubation with anti-ERG
Fig. 5 EHD4 is needed to form a junctional PACSIN2/EHD4/MICAL-L1 complex at asymmetric AJs. a Representative widefield images of asymmetric
AJs in HUVECs transduced with shControl, shEHD4-E1, and shEHD4-E10 stained for VE-cadherin (red) and EHD4 (green). The white squares indicate the
ROIs that are magnified in the right panels. The white arrow points to EHD4-positive asymmetric AJs. Imaging experiments were repeated three times with
similar results. b Representative Western blot analysis of EHD4 and vinculin (loading control) protein levels in whole-cell lysates from HUVECs transduced
with shControl, shEHD4-E1, or shEHD4-E10. The graph represents quantification of EHD4 protein levels in lysates of shEHD4 transduced HUVECs,
normalized to the levels of the protein in lysates from HUVECs transduced with shControl (n= 5 independent experiments). P < 0.0001 when comparing
shControl to shEHD4-E1 and when comparing shControl to shEHD4-E10. c Representative widefield images of asymmetric AJs in HUVECs transduced with
shControl, shEHD4-E1, and shEHD4-E10 stained for VE-cadherin (red) and PACSIN2 (green). The white squares indicate the ROIs that are magnified in the
right panels. d Quantification of the percentage of PACSIN2-positive asymmetric AJs in HUVECs transduced with shControl (n= 18 images), shEHD4-E1
(n= 24 images) or shEHD4-E10 (n= 16 images) from three independent experiments. P= 0.007 when comparing shControl to shEHD4-E1 and P= 0.008
when comparing shControl to shEHD4-E10. e Representative widefield images of asymmetric AJs in HUVECs transduced with shControl, shEHD4-E1,
and shEHD4-E10 stained for VE-cadherin (red) and MICAL-L1 (green). The white squares indicate the ROIs that are magnified in the right panels.
f Quantification of the percentage of MICAL-L1-positive asymmetric AJs in HUVECs transduced with shControl (n= 46 images), shEHD4-E1 (n= 44
images), or shEHD4-E10 (n= 51 images) from three independent experiments. P= 0.022 when comparing shControl to shEHD4-E1 and P= 0.0493 when
comparing shControl to shEHD4-E10. The graphs represent mean ± SEM (error bars). The statistical analyses were performed by a one-way ANOVA and
Dunnett’s multiple comparisons test. *P < 0.05, ***P < 0.001. Scale bars—20 and 5 µm (a, c, e). ROI region of interest, Arb. units arbitrary units. Source
data are provided as a Source Data file.
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antibody and its corresponding secondary, retinas were blocked for 2 h at RT with
the AffiniPure F(ab′)2 fragments Donkey anti-rabbit IgG (1/100, Cat# 711-006-
152) from Jackson ImmunoResearch. Retinas were washed three times in PBST
and fixed with 4% PFA at RT for 5 min. Next, retinas were washed with PBS
and blocked with blocking buffer for 30 min at 4 °C followed by incubation
with anti-GOLPH4 antibody in blocking buffer overnight at 4 °C. Finally, retinas
were incubated with the corresponding secondary antibody in Pblec as
described above.
Flow cytometry. HUVECs transduced with shControl, shPACSIN2, or shEHD4
were washed with PBS and detached with accutase on ice, and washed with FACS
buffer (0.1% BSA, 2-mM EDTA in PBS). Cells were incubated with anti-surface
VE-cadherin Alexa Fluor-647 conjugated antibody for 30 min at 4 °C and analyzed
on a CytoFLEX S Flow cytometer (Beckman Coulter Life Sciences).
Fluorescence microscopy. Standard IF stainings were imaged on a NIKON
Eclipse TI widefield microscope that was equipped with a lumencor SOLA SE II
light source, standard DAPI, CFP, GFP, mCherry, or Cy5 filter cubes, 10x CFI
Achromat dry objective (0.25 NA) or 60x Apo TIRF oil objective (1.49 NA), and an
Andor Zyla 4.2 plus sCMOS camera (Figs. 2g, j, 3e, 4h, i, 5, 6a and Supplementary
Figs. 4–7). Imaging of retinal stainings was performed on a LEICA SP5 confocal
equipped with 40x (1.25 NA) and 63x oil (1.40 NA) objectives and on a Leica TCS
SP8 confocal laser scanning microscope, with 10x, 40x oil (1.30 NA) and 63x oil
(1.40 NA) objectives using 405-nm UV diode and 470–670-nm White Light lasers
(Figs. 1, 2m, 7f, h, j and Supplementary Figs. 1a, 2, 8a). Colocalization studies in
Figs. 3b and 4b were performed with the SP8 confocal and 60× objective. Live cell
imaging was performed on HUVECs, which were seeded on Lab-Tek chambered
1.0 borosilicate coverglass slides coated with 5-µg ml−1 fibronectin. For live cell
imaging, we used the previously specified inverted NIKON Eclipse TI microscope
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CO2 gas chamber maintaining 37 °C and 5% CO2; (Figs. 2d, g, 6c–e, 7a and
Supplementary Movie 1, 3–6); or a Leica TCS SP8 SMD confocal laser scanning
microscope (Leica Microsystems), equipped with case incubator maintaining 37 °C
and 5% CO2, CS2 63 × /1.40 oil objective and 470–670-nm white light lasers
(Supplementary Fig. 3a and Supplementary Movie 2).
Immunolabeling for live imaging and VE-cadherin pulse-chase experiments.
For live imaging of VE-cadherin experiments, HUVECs were labeled with an Alexa
Fluor-647-conjugated Mouse Anti-Human CD144 non-blocking anti-extracellular
antibody (Clone 55-7H1; Cat # 561567) diluted 1/200 in EGM-2 at 37 °C. The
HUVECs were labeled 10–15 min prior to imaging and maintained in antibody-
containing media throughout the imaging experiment (Fig. 6e). For VE-cadherin
pulse-chase experiments (Fig. 6a), we pre-labeled the cells with the antibody for 30
min at 4 °C, washed the cells with PBS, and either fixed the HUVECs immediately
in 4% PFA in PBS++, or first cultured the cells at 37 °C for 2 h.
Wound-healing assay. HUVECs were cultured on 24-well plates or coverslips
coated with 5-µg ml−1 fibronectin. After reaching confluency, the monolayers were
scratched cross-wise with a p200 pipette tip and were washed with EGM-2. For live
imaging, the 24-well plates were mounted on an inverted NIKON Eclipse TI
microscope equipped with Okolab cage incubator and humidified CO2 gas
chamber maintaining 37 °C and 5% CO2. Phase-contrast live imaging of wound
closure was performed with 10x CFI Achromat DL dry objective (0.25 NA) and an
Andor Zyla 4.2 plus sCMOS camera for 16–18 h with a time interval of 10 or
15 min. For IF imaging, the coverslips were fixed in 4% PFA in PBS++ 5 h after
wounding and subsequently immuno-stained. For the competition scratch assays,
HUVECs transduced with shControl-RFP or shPACSIN2 and GFP were seeded as
mosaic monolayers in a 24-well plate coated with 5-µg ml−1 fibronectin. Scratch
wound migration was imaged overnight on an inverted NIKON Eclipse TI
microscope with a 20× objective using GFP and mCherry filter cubes (NIKON).
The ImageJ plugin for manual tracking was used for single-cell tracking, and the
Chemotaxis tool plugin was used to quantify velocity and directionality.
Particle image velocimetry (PIV) analysis. Particle image velocimetry (PIV) was
performed using PIVlab software implemented in MATLAB83. The velocity fields
of the time-lapses of wound-healing assays were determined using an interrogation
window set to 50 × 50 pixels with 50% overlap, enable clahe window size of 30
pixels, and applied to 10-h recordings with 15-min time interval. The mean velocity
correlation length was determined from exponential fitting of correlation curves
between neighboring windows using the v-component of the velocity using the
MATLAB code as in refs. 37,38.
Sprouting angiogenesis assay. For the angiogenic sprouting assay36, HUVECs
were resuspended in EGM-2 medium containing 0.1% methylcellulose (4000 cP,
Sigma, #M0512). For spheroid formation, 750 cells per 100-µl methylcellulose
medium were seeded in wells of a U-bottom 96-wells suspension plate and incu-
bated overnight. Next, glass-bottom 96-well plates were coated with 50 µl/well of
1.7-mg ml−1 Type I rat tail collagen (IBIDI, #50201) mixed with FCS and EGM-2
and placed at 37 °C for 30 min. Then, spheroids were collected and resuspended in
the collagen mixture and plated 50 µl/well on top of the coated glass-bottom 96-
well plates and placed at 37 °C. After polymerization of the collagen gel, spheroids
were stimulated with 50-ng ml−1 VEGF to induce sprouting overnight. Pictures
were acquired using an EVOS M7000 imaging system and 10× objective. Sprouting
number and length was analyzed using ImageJ.
Co-IP assay and Western blot analysis. Co-IP on untransduced HUVECs,
HUVECs ectopically expressing GFP, GFP-tagged PACSIN2 or EHD4 was per-
formed with magnetic GFP-Trap agarose beads from Chromotek (Cat # gtma-20).
Prior to the procedure, the magnetic beads were washed three times in PBS, two
times in lysis buffer, blocked for 1 h with 2% BSA in PBS at 4 °C and washed one
time with lysis buffer. Cells were lysed with freshly made ice-cold lysis buffer (20-
mM HEPES pH 7.4, 150-mM NaCl, 1,7-mM CaCl2, and 0.5% NP-40 supplemented
with cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail (Sigma-Aldrich)).
The lysates were homogenized with a Douncer homogenizer and sonicated thor-
oughly. The crude cell lysates were then incubated on ice for 30 min and cen-
trifuged at 12,000 g and 4 °C for 15 min. A portion of the supernatant was used as
whole lysate for Western Blot analysis. The rest of the supernatant was added to the
GFP-Trap-coupled beads, incubated overnight at 4 °C and then washed three times
with lysis buffer and PBS on ice. Immunoprecipitates were dissolved in reduced
sample buffer, boiled for 5 min and analyzed by Western Blot. Western Blot
analysis was performed according to standard Western Blot technique protocols.
All samples were taken up in reduced sample buffer. Images were acquired using
ImageQuant LAS4000 mini. Source data are provided as a Source Data file.
Image analysis and quantification. Images were acquired using Nikon Imaging
Software Elements and Leica Application Suite. Images were enhanced for display
with an unsharp mask filter or processed in ImageJ/Adobe Photoshop. All image
analyses for quantifications were performed in ImageJ. Overview and high-
resolution images of retinal IF are maximum intensity projections. Quantifications
were performed on the obtained high-resolution confocal images as follows:
endothelial branch points and proliferating cells were quantified behind the
angiogenic front in image field sizes of 100 × 100 μm. The number of sprouts,
length of the sprouts, number of endothelial cells, and clustering of cells were
quantified at the angiogenic front. The percentage of proliferating cells per unit
area in the sprouting front was based on cytoplasmic (dividing cells) versus nuclear
ERG (non-dividing cells) stainings. The total number of sprouts and the number of
endothelial cells was determined per 100 μm of the angiogenic front border. The
number of sprouting clusters was defined as three or more cells per sprout. The
number of ESM1+ cells at the sprouting front was calculated by dividing the
number of ESM1+ endothelial cells per number of total endothelial cells at the
sprouting front. VE-cadherin cytoplasmic intensity at the sprouting front was
determined by measuring the mean intensity of multiple fixed areas of interest
inside the vessels per image and subtracting the mean of the background signal
outside the vessels. Golgi orientation in retinas was measured by relating the
position of GOLPH4 signal to the center of the mass of the nucleus (ERG) in
relation with the vascular sprouting front and represented in a Rose plot showing
the angular distribution of individual Golgi orientation (performed in R). The
percentage of endothelial cells in the first three rows (tip and stalks cells) with the
Golgi polarized ±60° toward the sprouting front direction was determined. In
images from scratch wound assays, the boundaries of the wound were manually
marked and the decrease of the wounded surface area was measured over time to
quantify wound closure velocity. Golgi orientation was assessed by relating the
positioning of the GM130 signal to the center of mass of nucleus (DAPI) in relation
Fig. 6 EHD4 depletion perturbs VE-cadherin trafficking and asymmetric AJ remodeling during collective migration. a Widefield IF images of shControl,
shPACSIN2 (mix of D11+ E1), or shEHD4 (mix of E1+ E10) HUVECs that are pulse-labeled with anti-VE-cadherin antibodies (green) and stained for
nuclei (blue). Upper row represents the surface-labeled levels of VE-cadherin at t= 0 h, and the lower row images represent 2 h chased VE-cadherin.
b Quantification of the number of VE-cadherin-positive vesicles per cell. The data are from three independent experiments; shControl (n= 87 cells),
shPACSIN2 (n= 80 cells), and shEHD4 (n= 70 cells). P < 0.0001 when comparing shControl to shPACSIN2 and P= 0.0001 when comparing shControl to
shEHD4. cWidefield time-lapse images of asymmetric AJs in HUVECs expressing EHD4-GFP (green) and VE-cadherin-mCherry (red). White arrows point
to EHD4 recruitment, and the black filled arrowheads indicate the displacement direction of the AJs. See Supplementary Movie 3. d Widefield time-lapse
images of asymmetric AJs in shControl or shEHD4 (mix of E1+ E10) HUVECs expressing VE-cadherin-GFP. White arrows point to gradually turning over of
asymmetric AJs through subtle internalization events. Yellow arrowhead highlights the breaking of elongated asymmetric AJ in shEHD4 HUVECs. Heat
map in the right image panels shows the corresponding junction dynamics over 64min in a unique color per time frame. Note the gradual asymmetric AJ
turnover in shControl HUVECs. See Supplementary Movie 4. e Widefield images of HUVEC monolayers transduced with shControl or shEHD4 (mix of E1
+ E10) and live-labeled with anti-VE-cadherin antibody (white) at time t= 0 and t= 54min post-scratch wound induction. The yellow punctuated line
indicates the border of the scratch wound. The white squares indicate ROIs of remodeling asymmetric AJs between migrating HUVECs. See Supplementary
Movie 5 for time-lapse images of the wound closure. f Quantification of the maximal length of asymmetric AJs during the time-lapse recordings scratch
wound migration (54min). The data are from three independent experiments; shControl (n= 63 asymmetric AJs) and shEHD4 (n= 68 asymmetric AJs).
P= 0.0005 when comparing shControl to shEHD4. g Quantification of the lifetime of asymmetric AJs. The lifetime was defined as the time between
asymmetric AJ formation and the time of their breakdown. The data are from three independent experiments; shControl (n= 63 asymmetric AJs) and
shEHD4 (n= 68 asymmetric AJs). P < 0.0001 when comparing shControl to shEHD4. All graphs represent mean ± SEM (error bars) and the statistical
analysis was performed by a Kruskal–Wallis and Dunnett’s multiple comparisons test (b) or unpaired two-tailed t-test (f, g). ***P < 0.001. Scale bars—20
and 5 µm. VEC VE-cadherin, t time, Ab antibody, R region of interest, AJ adherens junction, Nr number. Source data are provided as a Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22873-y
14 NATURE COMMUNICATIONS |         (2021) 12:2610 | https://doi.org/10.1038/s41467-021-22873-y | www.nature.com/naturecommunications
to the scratch direction. Linescan analysis was performed using 3-µm long lines
that span asymmetric AJs measured the integrated intensity profile of the imaged
proteins. These profiles were background corrected with the integrated intensities
in 3-µm linescans in the cytoplasm in close proximity to the junction. Quantifi-
cations of the percentage of PACSIN2, EHD4, or MICAL-L1 positive junctions
were calculated as the ratio between all manually counted asymmetric AJs and
asymmetric AJs featuring the presence of tubular PACSIN2, EHD4, or MICAL-L1
signals, respectively. Colocalization of proteins at asymmetric AJs were assessed at
regions of interest around the tubular junctional structures and defined by the
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JACOP. The number of VE-cadherin-positive vesicles in pulse-chase experiments
was quantified as the number of vesicles detected in the cytoplasm using the Find
Maxima (prominence= 15000) and Analyze Particle (size= 0.1–1.5; circularity=
0.50–1.00) tools in ImageJ. Asymmetric AJs maximal length and lifetime during
wound closure were quantified by manually tracking remodeling AJs in the first
two rows of migrating cells from the moment of their formation. The intensity of
Western Blot bands was measured by the Gel Analyzer plugin in ImageJ.
Statistics. All data were analyzed using GraphPad Prism software. The graph error
bars represent mean ± SEM. Sample size and experimental replicates are indicated
in the figure legends. We used the nonparametric two-sided Mann−Whitney’s test,
the parametric Student’s t test, one-way ANOVA or Kruskal–Wallis with Dunnett’s
multiple comparison test, and a paired nonparametric Wilcoxon test. We desig-
nated P values in figures as: ns not significant; *P < 0.05; **P < 0.01; ***P < 0.001.
Fig. 7 EHD4 is needed for endothelial directed migration, in vitro angiogenic sprouting and coordination of angiogenesis in vivo. a Representative
phase-contrast images of scratch wound assays at 9 h and 40min post-scratch performed on HUVEC monolayers transduced with shControl, shEHD4-E1,
and shEHD4-E10. The punctuated yellow lines indicate the boundaries of the wound. See Supplementary Movie 6 for time-lapse images of the scratch
wound migration. b Quantification of wound-healing velocity measured in surface area per min of post-scratch HUVEC monolayers transduced with
shControl (n= 36 movies), shEHD4-E1 (n= 24 movies) and shEHD4-E10 (n= 35 movies) from three independent experiments. P < 0.0001 when
comparing shControl to shEHD4-E1 and when comparing shControl to shEHD4-E10. c Quantification of the correlation length of wound-healing time-lapse
recordings of HUVECs transduced with shControl (n= 19 movies), shEHD4-E1 (n= 17 movies), and shEHD4-E10 (n= 19 movies) from four independent
experiments using particle image velocimetry (PIV) analysis. P= 0.0384 when comparing shControl to shEHD4-E1 and P= 0.0035 when comparing
shControl to shEHD4-E10. d Representative phase-contrast images of sprouting spheroids from HUVECs transduced with shControl, shEHD4-E1, and
shEHD4-E10 after 16-h stimulation with VEGF. e Quantification of the number of sprouts per spheroid and the average sprout length of HUVECs
transduced with shControl (n= 35 spheroids), shEHD4-E1 (n= 30 spheroids), and shEHD4-E10 (n= 23 spheroids). Data are from three independent
experiments. P < 0.0001 when comparing shControl to shEHD4-E1 and when comparing shControl to shEHD4-E10. f Representative images of whole-
mount retinas stained for Isolectin B4 (IB4, red) and ERG (cyan) from control (Ehd4+/+) and Ehd4−/− mouse littermates at P6. g Quantification of the
number of branch points per unit area (at least seven retinas per genotype from three independent littermates), the number of sprouts and the number of
nuclei per 100 µm of sprouting front border (at least 16 retinas per genotype from at least three independent littermates) in the sprouting front of control
and Ehd4−/− P6 retinas. h Representative images of magnified sprouting front of retinas from control and Ehd4−/− mice at P6 stained for ERG (cyan) and
IB4 (red). Red punctuated lines indicate the sprouting front boundary. The red arrows indicate nuclear clusters in abnormal sprouts. i Quantification of the
average sprout length and the number of endothelial cell clusters at the sprouting front of control and Ehd4−/− P6 retinas (at least 11 retinas per genotype
from at least three independent littermates). P= 0.0268 when comparing the sprout length and P= 0.0290 when comparing the number of endothelial
clusters in Ehd4+/+ to Ehd4−/− retinas. j Representative high-resolution images of the sprouting front from control and Ehd4−/− retinas stained for VE-
cadherin (green), ERG (blue), and IB4 (red). The black dotted squares indicate the ROIs that are magnified in the panels below. k Quantification of the
intensity of cytoplasmic VE-cadherin at the vascular sprouts of control and Ehd4−/− retinas (n= 4 retinas per genotype, from two independent
littermates). All quantifications represent mean ± SEM (error bars), and statistical analysis was performed by a one-way ANOVA and Dunnett’s multiple
comparisons test in (b, c, e) and two-sided Mann–Whitney test in (g, i, k). ns non-significant; *P < 0.05; **P < 0.01; ***P < 0.001. Scale bars 100 µm (a, f),
50 µm (d), 40 µm (h), 10 and 5 µm (j). Arb. units arbitrary units. Source data are provided as a Source Data file.
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Fig. 8 Schematic representation of how the PACSIN2/EHD4/MICAL-L1 complex controls trafficking of VE-cadherin at asymmetric junctions.
Asymmetric adherens junctions are formed between leader and follower cells in migrating endothelial collectives. The F-BAR protein PACSIN2 as well as
the trafficking and recycling proteins EHD4 and MICAL-L1 are recruited to the rear of asymmetric junctions (a). The PACSIN2/EHD4/MICAL-L1 complex
enables the proper trafficking of VE-cadherin at the junction rear, ensuring gradual turnover of asymmetric junctions in support of collective migration
(b, c). In the absence of PACSIN2 or EHD4, this VE-cadherin trafficking systems fails, leading to asymmetric junction elongation and eventually ruptures
(a′, b′), resulting in an accumulation of internalized VE-cadherin levels (c′).
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source image data underlying Figs. 2a, 4d, f, 5b, and Supplementary Figs. 1c, d, e, 3b, 8c
are provided as a Source Data File. The numerical data underlying Figs. 1c, d, f, 2c, e, f, h,
i, l, n, o, 3c, d, g, 4c, e, g, j, k, l, 5b, d, f, 6b, f, g, 7b, c, e, g, i, k and Supplementary Figs. 4–6
are provided as a Source Data File. Additional datasets generated in the current study are
available from the corresponding author on request. Transgenic mice or detailed
information to generate them are available via M.P. Plasmids and other biological
materials are available from the corresponding author. Source data are provided with
this paper.
Code availability
Data analysis was performed with published and publicly available software.
Received: 11 March 2020; Accepted: 31 March 2021;
References
1. Cao, J. et al. Polarized actin and VE-cadherin dynamics regulate junctional
remodelling and cell migration during sprouting angiogenesis. Nat. Commun.
8, 2210 (2017).
2. Szymborska, A. & Gerhardt, H. Hold me, but not too tight—endothelial
cell–cell junctions in angiogenesis. Cold Spring Harb. Perspect. Biol. 10,
a029223 (2018).
3. Tatin, F. et al. Planar cell polarity protein Celsr1 regulates endothelial
adherens junctions and directed cell rearrangements during valve
morphogenesis. Dev. Cell. 26, 31–44 (2013).
4. Sauteur, L. et al. Cdh5/VE-cadherin promotes endothelial cell interface
elongation via cortical actin polymerization during angiogenic sprouting. Cell
Rep. 9, 504–513 (2014).
5. Blum, Y. et al. Complex cell rearrangements during intersegmental vessel
sprouting and vessel fusion in the zebrafish embryo. Dev. Biol. 316, 312–322
(2008).
6. Jakobsson, L. et al. Endothelial cells dynamically compete for the tip cell
position during angiogenic sprouting. Nat. Cell Biol. 12, 943–953 (2010).
7. Bentley, K. et al. The role of differential VE-cadherin dynamics in cell
rearrangement during angiogenesis. Nat. Cell Biol. 16, 309–321 (2014).
8. Arima, S. et al. Angiogenic morphogenesis driven by dynamic and
heterogeneous collective endothelial cell movement. Development 138,
4763–4776 (2011).
9. Vestweber D., Winderlich M., Cagna G., Nottebaum A. F. Cell adhesion
dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell
Biol. 19, 8–15 (2009).
10. Dejana, E., Orsenigo, F. & Lampugnani, M. G. The role of adherens junctions
and VE-cadherin in the control of vascular permeability. J. Cell Sci. 121,
2115–2122 (2008).
11. Dorland, Y. L. & Huveneers, S. Cell-cell junctional mechanotransduction in
endothelial remodeling. Cell Mol. Life Sci. 74, 279–292 (2017).
12. Lampugnani, M. G., Dejana, E. & Giampietro, C. Vascular endothelial (VE)-
cadherin, endothelial adherens junctions, and vascular disease. Cold Spring
Harb. Perspect. Biol. 10, a029322 (2018).
13. Vestweber, D. VE-cadherin: the major endothelial adhesion molecule
controlling cellular junctions and blood vessel formation. Arterioscler Thromb.
Vasc. Biol. 28, 223–232 (2008).
14. Malinova, T. S. & Huveneers, S. Sensing of cytoskeletal forces by asymmetric
adherens junctions. Trends Cell Biol. 28, 328–341 (2018).
15. Huveneers, S. et al. Vinculin associates with endothelial VE-cadherin
junctions to control force-dependent remodeling. J. Cell Biol. 196, 641–652
(2012).
16. Liu, Z. et al. Mechanical tugging force regulates the size of cell-cell junctions.
Proc. Natl Acad. Sci. USA 107, 9944–9949 (2010).
17. Tzima, E. et al. A mechanosensory complex that mediates the endothelial cell
response to fluid shear stress. Nature 437, 426–431 (2005).
18. Friedl, P. & Mayor, R. Tuning collective cell migration by cell-cell junction
regulation. Cold Spring Harb. Perspect. Biol. 9, a029199 (2017).
19. Dorland, Y. L. et al. The F-BAR protein pacsin2 inhibits asymmetric VE-
cadherin internalization from tensile adherens junctions. Nat. Commun. 7,
12210 (2016).
20. Chervin-Pétinot, A. et al. Epithelial protein lost in neoplasm (EPLIN) interacts
with α-catenin and actin filaments in endothelial cells and stabilizes vascular
capillary network in vitro. J. Biol. Chem. 287, 7556–7572 (2012).
21. Oldenburg, J. et al. VASP, zyxin and TES are tension-dependent members of
focal adherens junctions independent of the α-catenin-vinculin module. Sci.
Rep. 5, 17225 (2015).
22. Lagendijk, A. K. et al. Live imaging molecular changes in junctional tension
upon VE-cadherin in zebrafish. Nat. Commun. 8, 1402 (2017).
23. Millán, J. et al. Adherens junctions connect stress fibres between adjacent
endothelial cells. BMC Biol. 8, 11 (2010).
24. Barry, A. K., Wang, N. & Leckband, D. E. Local VE-cadherin
mechanotransduction triggers long-ranged remodeling of endothelial
monolayers. J. Cell Sci. 128, 1341–1351 (2015).
25. Gulino-Debrac, D. Mechanotransduction at the basis of endothelial barrier
function. Tissue Barriers 1, e24180 (2013).
26. Seddiki R., et al. Force-dependent binding of vinculin to α-catenin regulates
cell–cell contact stability and collective cell behavior. Mol. Biol. Cell. 29,
380–388 (2018).
27. Ng, M. R., Besser, A., Danuser, G. & Brugge, J. S. Substrate stiffness regulates
cadherin-dependent collective migration through myosin-II contractility. J.
Cell Biol. 199, 545–563 (2012).
28. Vitorino, P., Hammer, M., Kim, J. & Meyer, T. A steering model of endothelial
sheet migration recapitulates monolayer integrity and directed collective
migration. Mol. Cell Biol. 31, 342–350 (2011).
29. Chi, Q. et al. Rear actomyosin contractility-driven directional cell migration in
three-dimensional matrices: a mechano-chemical coupling mechanism. J. R.
Soc. Interface 11, 20131072 (2014).
30. Tountas, N. A. & Brautigan, D. L. Migration and retraction of endothelial and
epithelial cells require PHI-1, a specific protein-phosphatase-1 inhibitor
protein. J. Cell Sci. 117, 5905–5912 (2004).
31. Efimova, N. & Svitkina, T. M. Branched actin networks push against each
other at adherens junctions to maintain cell-cell adhesion. J. Cell Biol. 217,
1827–1845 (2018).
32. Peglion, F., Llense, F. & Etienne-Manneville, S. Adherens junction
treadmilling during collective migration. Nat. Cell Biol. 16, 639–651 (2014).
33. Hayer, A. et al. Engulfed cadherin fingers are polarized junctional structures
between collectively migrating endothelial cells. Nat. Cell Biol. 18, 1311–1323
(2016).
34. Semmler, J. et al. Pacsin 2 is required for the maintenance of a normal cardiac
function in the developing mouse heart. Pharm. Res. 128, 200–210 (2018).
35. Angulo-Urarte, A. et al. Endothelial cell rearrangements during vascular
patterning require PI3-kinase-mediated inhibition of actomyosin contractility.
Nat. Commun. 9, 4826 (2018).
36. Heiss, M. et al. Endothelial cell spheroids as a versatile tool to study
angiogenesis in vitro. FASEB J. 29, 3076–3084 (2015).
37. Vedula, S. R. K. et al. Emerging modes of collective cell migration induced by
geometrical constraints. Proc. Natl Acad. Sci. USA 109, 12974–12979 (2012).
38. Petitjean, L. et al. Velocity fields in a collectively migrating epithelium.
Biophys. J. 98, 1790–1800 (2010).
39. Ladoux, B., Mège, R.-M. & Trepat, X. Front–rear polarization by mechanical
cues: from single cells to tissues. Trends Cell Biol. 26, 420–433 (2016).
40. Vassilev, V., Platek, A., Hiver, S., Enomoto, H. & Takeichi, M. Catenins steer
cell migration via stabilization of front-rear polarity. Dev. Cell 43, 463–479.e5
(2017).
41. Xing, M. et al. GOLPH3 drives cell migration by promoting Golgi
reorientation and directional trafficking to the leading edge.Mol. Biol. Cell. 27,
3828–3840 (2016).
42. Franco C. A., et al. Dynamic endothelial cell rearrangements drive
developmental vessel regression. PLoS Biol. 13, e1002125 (2015).
43. Ulrich, F. & Heisenberg, C.-P. Trafficking and cell migration. Traffic 10,
811–818 (2009).
44. Palacios, F., Price, L., Schweitzer, J., Collard, J. G. & D’Souza‐Schorey, C. An
essential role for ARF6-regulated membrane traffic in adherens junction
turnover and epithelial cell migration. EMBO J. 20, 4973–4986 (2001).
45. Venhuizen, J.-H. & Zegers, M. M. Making heads or tails of it: cell-cell adhesion
in cellular and supracellular polarity in collective migration. Cold Spring Harb.
Perspect. Biol. 9, a027854 (2017).
46. Cadwell, C. M., Su, W. & Kowalczyk, A. P. Cadherin tales: regulation of
cadherin function by endocytic membrane trafficking. Traffic 17, 1262–1271
(2016).
47. Nanes B. A. et al. p120-catenin regulates VE-cadherin endocytosis and
degradation induced by the Kaposi sarcoma–associated ubiquitin ligase K5.
Mol. Biol. Cell. 28, 30–40 (2017).
48. Nanes, B. A. et al. p120-catenin binding masks an endocytic signal conserved
in classical cadherins. J. Cell Biol. 199, 365–380 (2012).
49. Chiasson, C. M., Wittich, K. B., Vincent, P. A., Faundez, V. & Kowalczyk, A.
P. p120-Catenin inhibits VE-cadherin internalization through a Rho-
independent mechanism. Mol. Biol. Cell. 20, 1970–1980 (2009).
50. Kowalczyk, A. P. & Nanes, B. A. Adherens junction turnover: regulating
adhesion through cadherin endocytosis, degradation, and recycling. Subcell.
Biochem. 60, 197–222 (2012).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22873-y ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:2610 | https://doi.org/10.1038/s41467-021-22873-y | www.nature.com/naturecommunications 17
51. Grimsley-Myers C. M., et al. VE-cadherin endocytosis controls vascular
integrity and patterning during development. J Cell Biol. 219, e201909081
(2020).
52. de Beer, T. et al. Molecular mechanism of NPF recognition by EH domains.
Nat. Struct. Biol. 7, 1018–1022 (2000).
53. Naslavsky, N. & Caplan, S. EHD proteins: key conductors of endocytic
transport. Trends Cell Biol. 21, 122–131 (2011).
54. Cullen, P. J. & Steinberg, F. To degrade or not to degrade: mechanisms and
significance of endocytic recycling. Nat. Rev. Mol. Cell Biol. 19, 679–696
(2018).
55. Naslavsky, N. & Caplan, S. The enigmatic endosome—sorting the ins and outs
of endocytic trafficking. J. Cell Sci. 131, jcs216499 (2018).
56. Giridharan, S. S. P., Cai, B., Vitale, N., Naslavsky, N. & Caplan, S. Cooperation
of MICAL-L1, syndapin2, and phosphatidic acid in tubular recycling
endosome biogenesis. Mol. Biol. Cell. 24, 1776–1790 (2013).
57. Braun, A. et al. EHD proteins associate with syndapin I and II and such
interactions play a crucial role in endosomal recycling. Mol. Biol. Cell. 16,
3642–3658 (2005).
58. Sharma, M., Naslavsky, N. & Caplan, S. A role for EHD4 in the regulation of
early endosomal transport. Traffic 9, 995–1018 (2008).
59. Sharma, M., Srinivas Panapakkam Giridharan, S., Rahajeng, J., Caplan, S. &
Naslavsky, N. MICAL-L1: an unusual Rab effector that links EHD1 to tubular
recycling endosomes. Commun. Integr. Biol. 3, 181–183 (2010).
60. Sharma, M., Panapakkam Giridharan, S. S., Rahajeng, J., Naslavsky, N. &
Caplan, S. MICAL-L1 links EHD1 to tubular recycling endosomes and
regulates receptor recycling. Mol. Biol. Cell. 20, 5181–5194 (2009).
61. Lecuit T., Yap A. S. E-cadherin junctions as active mechanical integrators in
tissue dynamics. Nat. Cell Biol. 17, 533–539 (2015).
62. Takeichi M. Dynamic contacts: rearranging adherens junctions to drive
epithelial remodelling. Nat. Rev. Mol. Cell Biol. 15, 397–410 (2014).
63. Ladoux, B. & Mège, R. M. Mechanobiology of collective cell behaviours. Nat.
Rev. Mol. Cell Biol. 18, 743–757 (2017).
64. Yap A. S., Duszyc K., Viasnoff V. Mechanosensing and mechanotransduction
at cell–cell junctions. Cold Spring Harb. Perspect. Biol. 10, a028761 (2018).
65. Webb, D. J., Parsons, J. T. & Horwitz, A. F. Adhesion assembly, disassembly
and turnover in migrating cells—over and over and over again. Nat. Cell Biol.
4, E97–E100 (2002).
66. Linford, A. et al. Rab14 and its exchange factor FAM116 link endocytic
recycling and adherens junction stability in migrating cells. Dev. Cell 22,
952–966 (2012).
67. Kawauchi, T. et al. Rab GTPases-dependent endocytic pathways regulate
neuronal migration and maturation through N-cadherin trafficking. Neuron
67, 588–602 (2010).
68. Brüser, L. & Bogdan, S. Adherens junctions on the move-membrane
trafficking of E-cadherin. Cold Spring Harb. Perspect. Biol. 9, a029140 (2017).
69. Xue, N., Bertulli, C., Sadok, A. & Huang, Y. Y. S. Dynamics of filopodium-like
protrusion and endothelial cellular motility on one-dimensional extracellular
matrix fibrils. Interface Focus 4, 20130060 (2014).
70. Barlan, K., Cetera, M. & Horne-Badovinac, S. Fat2 and Lar define a basally
localized planar signaling system controlling collective cell migration. Dev.
Cell 40, 467–477.e5 (2017).
71. Insinna, C. et al. Investigation of F-BAR domain PACSIN proteins uncovers
membrane tubulation function in cilia assembly and transport. Nat. Commun.
10, 428 (2019).
72. Bahl, K. et al. EHD3 protein is required for tubular recycling endosome
stabilization, and an asparagine-glutamic acid residue pair within its Eps15
homology (EH) domain dictates its selective binding to NPF peptides. J. Biol.
Chem. 291, 13465–13478 (2016).
73. Deo R. et al. ATP-dependent membrane remodeling links EHD1 functions to
endocytic recycling. Nat. Commun. 9, 5187 (2018).
74. Van Duyne R., Freed E. O. HIV-1 packs in PACSIN2 for cell-to-cell spread.
Proc. Natl Acad. Sci. USA 115, 6885–6887 (2018).
75. Popov, S., Popova, E., Inoue, M., Wu, Y. & Göttlinger, H. HIV-1 gag recruits
PACSIN2 to promote virus spreading. Proc. Natl Acad. Sci. USA 115,
7093–7098 (2018).
76. Conway D. E., Schwartz M. A. Mechanotransduction of shear stress occurs
through changes in VE-cadherin and PECAM-1 tension: Implications for cell
migration. Cell Adh. Migr.9, 335–339 (2015).
77. Kim, T.-J. et al. Dynamic visualization of α-catenin reveals rapid, reversible
conformation switching between tension states. Curr. Biol. 25, 218–224
(2015).
78. Andresen Eguiluz, R. C., Kaylan, K. B., Underhill, G. H. & Leckband, D. E.
Substrate stiffness and VE-cadherin mechano-transduction coordinate to
regulate endothelial monolayer integrity. Biomaterials 140, 45–57 (2017).
79. Modregger, J., Ritter, B., Witter, B., Paulsson, M. & Plomann, M. All three
PACSIN isoforms bind to endocytic proteins and inhibit endocytosis. J. Cell
Sci. 113, 4511–4521 (2000).
80. Root, D. E., Hacohen, N., Hahn, W. C., Lander, E. S. & Sabatini, D. M.
Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat.
Methods 3, 715–719 (2006).
81. Jeong, J. Y. et al. One-step sequence-and ligation-independent cloning as a
rapid and versatile cloning method for functional genomics Studies. Appl
Environ. Microbiol. 78, 5440–5443 (2012).
82. Carvalho J. R. et al. Non-canonical Wnt signaling regulates junctional
mechanocoupling during angiogenic collective cell migration. Elife 8,
e45853 (2019).
83. Thielicke W., Stamhuis E. J. PIVlab—towards user-friendly, affordable and
accurate digital particle image velocimetry in MATLAB. J. Open Res. Softw. 2,
p.e30 (2014).
Acknowledgements
We are grateful to Prof. Dr Steve Caplan (University of Nebraska Medical Center, US) for
providing the peGFP-EHD4 plasmid, Prof. Dr René-Marc Mège for sharing expertise
with the MATLAB correlation code (Paris Diderot University, France), and Dr Peter
Stroeken (Amsterdam UMC, University of Amsterdam, the Netherlands) for providing
lentiviral shRNAs from the MISSION library (Sigma-Aldrich) of the RNAi Consortium.
We thank the Cellular Imaging core facility of the Amsterdam UMC for technical
support. The group of S.H. is financially supported by the Netherlands Organization of
Scientific Research (ZonMW VIDI Grant 016.156.327 and NWO OCENW.KLEIN.281).
M.P. is supported by the German Research Foundation (PL 233/3-3). IDIBELL is a
member of Centres de Recerca de Catalunya (CERCA), and M.G. is supported by
research Grants SAF2017-89116R-P from MCIU (Spain) co-funded by European
Regional Developmental Fund (ERDF) a Way to Build Europe, La Caixa Foundation
(HR18-00120), la Asociación Española contra el Cancer (AECC)-Grupos Traslacionales
(GCTRA18006CARR), and la Fundación BBVA.
Author contributions
T.S.M., A.A.-U., and S.H. conceived and designed the study. T.S.M., A.A.-U., M.M.v.d.S,
V.J., A.d.H., A.G.G., M.T., and S.H. designed, performed, collected data, and analyzed the
cell-based in vitro experiments. T.S.M., A.A.-U., J.N., M.T., M.G., M.P., and S.H.
designed, performed, collected data, and analyzed the mouse-based experiments. T.S.M.,
A.A.-U., and S.H. wrote the manuscript. All authors discussed the results and reviewed
the manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41467-021-22873-y.
Correspondence and requests for materials should be addressed to S.H.
Peer review information Nature Communications thanks the anonymous reviewers for
their contribution to the peer review of this work. Peer reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2021
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22873-y
18 NATURE COMMUNICATIONS |         (2021) 12:2610 | https://doi.org/10.1038/s41467-021-22873-y | www.nature.com/naturecommunications
